Education
About Us
Working with TipRanks
Follow Us
T2 Biosystems (TTOO)
OTHER OTC:TTOO
TTOO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $6.80
Previous CloseN/A
Volume266.95K
Average Volume (3M)1.75M
Market Cap
$3.70M
Enterprise Value$52.11M
Total Cash (Recent Filing)$50.80M
Total Debt (Recent Filing)$43.13M
Price to Earnings (P/E)―
Beta-2.56
Next Earnings
May 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.41
Shares Outstanding28,045,418
10 Day Avg. Volume209,638
30 Day Avg. Volume1,747,467
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.48
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap14.08
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-6.38
Enterprise Value/Ebitda-1.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
T2 Biosystems News
PremiumCompany Announcements
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice
PremiumCompany Announcements
T2 Biosystems Enhances Governance and Leadership Stability
PremiumCompany Announcements
T2 Biosystems Advances Sepsis Detection Technology Licensing---
Ownership Overview
16.87% Insiders
1.64% Mutual Funds
0.22% Other Institutional Investors
80.72% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TTOO FAQ
What was T2 Biosystems’s price range in the past 12 months?
T2 Biosystems lowest stock price was $0.06 and its highest was $6.80 in the past 12 months.
What is T2 Biosystems’s market cap?
T2 Biosystems’s market cap is $3.70M.
When is T2 Biosystems’s upcoming earnings report date?
T2 Biosystems’s upcoming earnings report date is May 13, 2025 which is in 62 days.
How were T2 Biosystems’s earnings last quarter?
Currently, no data Available
Is T2 Biosystems overvalued?
According to Wall Street analysts T2 Biosystems’s price is currently Overvalued.
Does T2 Biosystems pay dividends?
T2 Biosystems does not currently pay dividends.
What is T2 Biosystems’s EPS estimate?
T2 Biosystems’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does T2 Biosystems have?
T2 Biosystems has 28,045,418 shares outstanding.
What happened to T2 Biosystems’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of T2 Biosystems?
Among the largest hedge funds holding T2 Biosystems’s share is Invst, LLC. It holds T2 Biosystems’s shares valued at 0.
---
Company Description
T2 Biosystems
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
---
TTOO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
T2 Biosystems demonstrated significant revenue growth and strategic partnerships, notably with Cardinal Health, which could drive future success. However, financial challenges such as a substantial net loss and NASDAQ compliance issues are concerning. The sentiment is balanced by the potential of new product launches and operational improvements.Read More>---
TTOO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---